16 Citations (Scopus)

Abstract

Selenium is an essential trace element for humans and other animals that is required in very small amounts for proper growth and functioning. Several selenium compounds have shown promise as cancer chemopreventive and chemotherapeutic agents. However, the negative outcome of the SELECT trial to some extent dampened the enthusiasm of selenium-related drug development. A look at the selenium compounds, their diverse mechanism of action, bioavailability and efficacy based on chemical structure, however, suggests that failure of SELECT that used selenomethionine supplement to prevent prostate cancer was not a failure of selenium compounds as a whole. This is certainly true in regard to therapeutic applications of selenium compounds. This article puts these arguments in perspective, and based on the literature reports, especially several newly developed selenium compounds, emphasizes the importance of selenium in the development of chemopreventive and particularly chemotherapeutic drugs for cancer in near future.

Original languageEnglish (US)
Pages (from-to)163-174
Number of pages12
JournalFuture Medicinal Chemistry
Volume5
Issue number2
DOIs
StatePublished - Feb 1 2013

Fingerprint

Selenium Compounds
Selenium
Selenomethionine
Trace Elements
Pharmaceutical Preparations
Biological Availability
Neoplasms
Prostatic Neoplasms
Growth

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

@article{50911e6ebea547bd8fe97f97fdc71039,
title = "Post SELECT: Selenium on trial",
abstract = "Selenium is an essential trace element for humans and other animals that is required in very small amounts for proper growth and functioning. Several selenium compounds have shown promise as cancer chemopreventive and chemotherapeutic agents. However, the negative outcome of the SELECT trial to some extent dampened the enthusiasm of selenium-related drug development. A look at the selenium compounds, their diverse mechanism of action, bioavailability and efficacy based on chemical structure, however, suggests that failure of SELECT that used selenomethionine supplement to prevent prostate cancer was not a failure of selenium compounds as a whole. This is certainly true in regard to therapeutic applications of selenium compounds. This article puts these arguments in perspective, and based on the literature reports, especially several newly developed selenium compounds, emphasizes the importance of selenium in the development of chemopreventive and particularly chemotherapeutic drugs for cancer in near future.",
author = "Arun Sharma and Shantu Amin",
year = "2013",
month = "2",
day = "1",
doi = "10.4155/fmc.12.203",
language = "English (US)",
volume = "5",
pages = "163--174",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science",
number = "2",

}

Post SELECT : Selenium on trial. / Sharma, Arun; Amin, Shantu.

In: Future Medicinal Chemistry, Vol. 5, No. 2, 01.02.2013, p. 163-174.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Post SELECT

T2 - Selenium on trial

AU - Sharma, Arun

AU - Amin, Shantu

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Selenium is an essential trace element for humans and other animals that is required in very small amounts for proper growth and functioning. Several selenium compounds have shown promise as cancer chemopreventive and chemotherapeutic agents. However, the negative outcome of the SELECT trial to some extent dampened the enthusiasm of selenium-related drug development. A look at the selenium compounds, their diverse mechanism of action, bioavailability and efficacy based on chemical structure, however, suggests that failure of SELECT that used selenomethionine supplement to prevent prostate cancer was not a failure of selenium compounds as a whole. This is certainly true in regard to therapeutic applications of selenium compounds. This article puts these arguments in perspective, and based on the literature reports, especially several newly developed selenium compounds, emphasizes the importance of selenium in the development of chemopreventive and particularly chemotherapeutic drugs for cancer in near future.

AB - Selenium is an essential trace element for humans and other animals that is required in very small amounts for proper growth and functioning. Several selenium compounds have shown promise as cancer chemopreventive and chemotherapeutic agents. However, the negative outcome of the SELECT trial to some extent dampened the enthusiasm of selenium-related drug development. A look at the selenium compounds, their diverse mechanism of action, bioavailability and efficacy based on chemical structure, however, suggests that failure of SELECT that used selenomethionine supplement to prevent prostate cancer was not a failure of selenium compounds as a whole. This is certainly true in regard to therapeutic applications of selenium compounds. This article puts these arguments in perspective, and based on the literature reports, especially several newly developed selenium compounds, emphasizes the importance of selenium in the development of chemopreventive and particularly chemotherapeutic drugs for cancer in near future.

UR - http://www.scopus.com/inward/record.url?scp=84873290591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873290591&partnerID=8YFLogxK

U2 - 10.4155/fmc.12.203

DO - 10.4155/fmc.12.203

M3 - Review article

C2 - 23360141

AN - SCOPUS:84873290591

VL - 5

SP - 163

EP - 174

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 2

ER -